GlassScriptPhysician profile
Joby Joseph
NPI 1295799245
$1,992.32
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $934 · 2020: $53.88 · 2021: $206 · 2022: $708 · 2023: $90.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $90.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $90.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $550.94 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $430.51 | 2019-2022 | |
| Ucb, INC. | $197.67 | 2019-2022 | |
| Pfizer INC. | $161.51 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $120.32 | 2021 | |
| Amgen INC. | $101.56 | 2019-2022 | |
| Greenwich Biosciences, INC. | $99.38 | 2019 | |
| Eisai INC. | $63.81 | 2019-2020 | |
| Biogen, INC. | $59.52 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $54.08 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $45.03 | 2022 | |
| Neurocrine Biosciences, INC. | $42.75 | 2022 | |
| Sk Life Science, INC. | $22.50 | 2022 | |
| Lilly USA, LLC | $17.03 | 2022 | |
| Emd Serono, INC. | $13.81 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $11.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joby Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.